|Search || Browse|
|Opens resource in a 2nd browser window.|
Adolor is committed to the development of novel analgesic and related therapeutics based upon recent advances in proprietary medicinal chemistry and recombinant receptor technology.
Producer of sofware for the analysis of fingerprints (GelComparII), of genomic sequences (Kodon)and micro-arrays (GeneMaths). With the package BioNumerics, all these different types of data can be integrated, stored and compared. Oracle, SQL, Access, … compatible. Full package for the acquisition, storage and analysis of epidemiological and biological information.
Bio-Rad Laboratories, Inc.
Bio-Rad specializes in electrophoresis and chromatography techniques, and develops and manufactures instruments and chemicals for analysis, separation, and production of biological molecules such as proteins, peptides, and nucleic acids.
BioTime is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery.
Catalytica focuses on catalytic process technology through the use of molecularly designed proprietary catalysts for transformation of efficient and cleaner industrial processes.
Cellomics’ mission is to improve the efficiency of the drug discovery process by delivering a cell-based screening platform that automates target validation and lead optimization using fluorescence-based assays.
Celsus Laboratories, Inc
Celsus Laboratories, Inc. manufactures and tests GAGs used in injectable drugs, blood collection, blood gas analysis devices, and thromboresistant coatings for blood-interacting biomaterials.
Chiron has research programs in recombinant proteins, combinatorial chemistry, and gene therapy. Chiron also participates in diagnostics, therapeutics, and pediatric and adult vaccines.
Digital Gene Technolgies, Inc.
Digital Gene Technologies, Inc. combines patented genomics technology with advanced bioinformatics to identify and determine anatomical distribution and expression patterns of the genes contained in any cell or tissue sample.
Dyadic Industries International, LTD., Incorporated
The Dyadic Group Companies develop and manufacture industrial enzymes, minerals, chemical formulations, and processing aids for the natural fiber and food processing industries.
Dynal Biotech is the supplier of Dynabeads. Superparamagnetic, monodisperse Dynabeads are key to the leading technology of magnetic isolation of cells, proteins and genetic material. Dynal Biotech offers magnetic separation solutions in the areas of immunology and molecular biology. In addition, we offer a wide range of non-magnetic particles and products for HLA tissue typing.
Exelixis Pharmaceuticals, Inc.
Exelixis Pharmaceuticals uses model organism genetics and related technologies for the identification and validation of high-quality screening targets, therapeutic proteins, and biopesticides for the pharmaceutical and animal health industries.
ExpressGen provides full length gene cloning and gene expression in bacterial, insect, and mammalian expression systems; and recombinant protein purification services to academia, biotech, and pharmaceutical companies.
The Institute for Genomic Research
The Institute for Genomic Research develops structure, function, and comparative analyses of genomes and genome products between prokaryotes and eukaryotes in databases.
Neose Technologies, Inc.
Neose Technologies is developing a broad proprietary technology platform for the enzymatic synthesis, manufacture, and commercialization of complex carbohydrates for nutritional, pharmaceutical, consumer, and industrial uses.
Rapigene is distinguished by its proprietary nucleic acid measurement technologies platform, including the precise and quantitative Masscode tagging system that allows multiple simultaneous measurements.
Sangamo BioSciences, Inc.
Sangamo is a privately held biotechnology company focused on the rational design of novel transcription factors for the recognition and regulation of mammalian, plant, and microbial gene targets.
Sequus Pharmaceuticals, Inc.
Sequus Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceuticals to treat cancer and infectious disease using liposome and lipid-based technologies.
ThermoGen, Inc. develops stable enzymes and other proteins from the